Atropine

阿托品

Report date: 2024/01/31 20:05:50

Base Information

Drug NameAtropine
Drug Alias NameAtropine sulfate(Cloudbreak Therapeutics)CBT-009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPoisoningMyopia, DegenerativeMyopia
Global Approved IndicationsPoisoning
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1973/05/15
Country/TerritoryUnited StatesMexicoAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCloudbreak Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Sophia Sa De CvMansoura UniversityCloudbreak Therapeutics Llc
Inactive CompaniesThe Ohio State UniversityMeridian Medical Technologies Inc
Active IndicationsMyopia, DegenerativeMyopia
Inactive IndicationsPoisoning

Other Information

ATC CodeN/A
Related LinksN/A